193 related articles for article (PubMed ID: 35783010)
1. The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.
Fu L; Zhang G; Wang Y; Lu T; Liu B; Jiao Y; Ma H; Ma S; Yang K; Cai H
Dis Markers; 2022; 2022():4466776. PubMed ID: 35783010
[TBL] [Abstract][Full Text] [Related]
2. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
4. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
Shu Q; Liu X; Yang J; Mou T; Xie F
Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.
Luo H; Zhang Y; Qin G; Jiang B; Miao L
BMC Cancer; 2021 Jul; 21(1):820. PubMed ID: 34271873
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1.
Zhou M; Bian Z; Liu B; Zhang Y; Cao Y; Cui K; Sun S; Li J; Zhang J; Wang X; Li C; Yao S; Yin Y; Fei B; Huang Z
Cancer Med; 2021 Apr; 10(7):2470-2481. PubMed ID: 33686713
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis.
Dai W; Zeng W; Lee D
J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
9. The role of LncRNA MCM3AP-AS1 in human cancer.
Azizidoost S; Ghaedrahmati F; Sheykhi-Sabzehpoush M; Uddin S; Ghafourian M; Mousavi Salehi A; Keivan M; Cheraghzadeh M; Nazeri Z; Farzaneh M; Khoshnam SE
Clin Transl Oncol; 2023 Jan; 25(1):33-47. PubMed ID: 36002764
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
Zhou X; Fan YH; Wang Y; Wang F; Liu Y
Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
[TBL] [Abstract][Full Text] [Related]
12. YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.
Li X; Yu M; Yang C
J Cell Biochem; 2020 Mar; 121(3):2258-2267. PubMed ID: 31693222
[TBL] [Abstract][Full Text] [Related]
13. MCM3AP-AS1: A LncRNA Participating in the Tumorigenesis of Cancer Through Multiple Pathways.
Wang B; Chen J; Lin C; Liu R; Wang L; Yuan C
Mini Rev Med Chem; 2022; 22(16):2138-2145. PubMed ID: 35156580
[TBL] [Abstract][Full Text] [Related]
14. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract][Full Text] [Related]
16. LncRNA
Nian R; Li W; Li X; Zhang J; Li W; Pan F; Cheng J; Jin X
Arch Endocrinol Metab; 2023 Jan; 67(1):55-63. PubMed ID: 35929906
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MCM3AP-AS1 Downregulates LncRNA MEG3 in Triple Negative Breast Cancer to Inhibit the Proliferation of Cancer Cells.
Ren G; Han G; Song Z; Zang A; Liu B; Hu L; Jia L; Hong D; Yang L; Qie S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):81-87. PubMed ID: 34587438
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MCM3AP-AS1 Regulates miR-21/PTEN Axis to Affect Cervical Squamous Cell Carcinoma Cell Proliferation and Apoptosis.
Yan G; Wan Z; Zhong Y; Chen M
Crit Rev Eukaryot Gene Expr; 2022; 32(4):49-56. PubMed ID: 35695665
[TBL] [Abstract][Full Text] [Related]
19. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA).
Yan Z; Lu J; Xu X; You Y; Xu J; Xu T
Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
Tang L; Liu QM; Zhang S; Zhou J
Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
